Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001770982 | SCV001993954 | uncertain significance | not provided | 2019-07-10 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function |
Fulgent Genetics, |
RCV002488551 | SCV002784282 | uncertain significance | Atelosteogenesis type III; Atelosteogenesis type I; Boomerang dysplasia; Spondylocarpotarsal synostosis syndrome; Larsen syndrome | 2021-08-16 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004536288 | SCV004109868 | uncertain significance | FLNB-related disorder | 2023-04-24 | criteria provided, single submitter | clinical testing | The FLNB c.3325G>A variant is predicted to result in the amino acid substitution p.Val1109Ile. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0056% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/3-58109018-G-A). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |
Labcorp Genetics |
RCV001770982 | SCV004510342 | likely benign | not provided | 2024-10-20 | criteria provided, single submitter | clinical testing |